Nutriband Inc (NTRB)
4.89
+0.08
(+1.66%)
USD |
NASDAQ |
Nov 14, 16:00
4.89
0.00 (0.00%)
After-Hours: 20:00
Nutriband Research and Development Expense (Quarterly): 0.774M for July 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 0.774M |
| April 30, 2024 | 0.9745M |
| January 31, 2024 | 0.5634M |
| October 31, 2023 | 0.5515M |
| July 31, 2023 | 0.4451M |
| April 30, 2023 | 0.4004M |
| January 31, 2023 | 0.2958M |
| October 31, 2022 | 0.2907M |
| Date | Value |
|---|---|
| July 31, 2022 | 0.2779M |
| April 30, 2022 | 0.1178M |
| January 31, 2022 | 0.2504M |
| October 31, 2021 | 0.161M |
| July 31, 2021 | 0.00 |
| April 30, 2021 | 0.00 |
| January 31, 2021 | 0.00 |
| October 31, 2020 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Oct 2020
0.9745M
Maximum
Apr 2024
0.3189M
Average
0.2843M
Median
Research and Development Expense (Quarterly) Benchmarks
| NeuroOne Medical Technologies Corp | 1.195M |
| SINTX Technologies Inc | 1.677M |
| enVVeno Medical Corp | 2.859M |
| Beyond Air Inc | 6.009M |
| CVRx Inc | 2.504M |